Choose the best stocks, bonds, view reports, dividends, create portfolios, earn!
GET STARTED FOR FREE
You can
Choose bonds with the highest yield
Create, edit and share a portfolio
Choose undervalued stocks with good potential returns
View future and past dividends in a convenient format
Instantly learn about decisions of shareholders and councils of directors with a notification system
Tariffs
$0
per 1 year
Basic
Reporting and multipliers
Analytical reviews
Dividend history
Personal notifications about dividends
Investment accounting
1 portfolio
Assets in portfolio
7 assets
Favourite issuers
5 issuers
$80
per 1 year
Professional
Reporting and multipliers
2200+ companies
Analytical reviews
Dividend history
Personal notifications about dividends
Investment accounting
10 portfolios
Assets in portfolio
Favourite issuers
1000 issuers
Stock market news
Net profit of Kazanorgsintez under IFRS for 6 months of 2026 amounted to ₽2.91 billion, a 2.6‑fold decrease compared to ₽7.65 billion in the previous year. Revenue decreased by 3.9% to ₽54.4 billion,...
Net profit of Nizhnekamskneftekhim under IFRS for 6 months of 2026 amounted to RUB 1.6 billion, a 16‑fold decrease compared to RUB 26.5 billion in the previous year. Revenue decreased by 6.1% to RUB 1...
Net profit of the Lipetsk Energy Sales Company under IFRS for 6 months of 2026 amounted to RUB 788.07 million, an increase of 72.7 % compared to RUB 456.22 million in the previous year. Revenue decrea...
Board of Directors of Ozon Pharmaceuticals recommended that dividends be paid for II quarter 2026 in the amount of ₽0.49 per ordinary share. The last day of the purchase of securities to receive divid...
Sales of Ozon Pharmaceuticals for 6 months of 2026 amounted to 151.1 million packages of medicinal products, a 1% decrease compared to the previous year. In the government procurement segment, sales i...
Net profit of Ozon Pharmaceuticals under IFRS for 6 months of 2026 amounted to RUB 3.25 billion, doubling compared to RUB 1.71 billion in the previous year. Revenue increased by 11.3% to RUB 14.8 bill...
GloraX has received permission to build the second of three stages of the business‑class project Levoberezhny in Nizhny Novgorod. As part of the second stage, the company will build 16,189 square metr...
Net profit of Saratovenergo under IFRS for 6 months of 2026 amounted to ₽184.9 million, which is 62.8% lower compared to ₽497.3 million in the previous year. Revenue increased by 16% to ₽15.2 billion,...
Net profit of DOM.RF under IFRS for 7 months of 2026 amounted to ₽67 billion, an increase of 44.1% compared to ₽46.5 billion in the previous year. Net interest income (excluding securitization transac...
MTS’s net profit under IFRS for 6 months of 2026 amounted to ₽75.9 billion, an 8.5‑fold increase compared to ₽8.9 billion in the previous year. Revenue grew by 11.8% to ₽414.7 billion, compared to ₽37...
MTS Bank’s net profit under IFRS for 6 months of 2026 amounted to ₽7.24 billion, doubling compared to ₽3.47 billion in the previous year. Net interest income increased by 47.9% to ₽28.7 billion, up fr...
Board of Directors of Zaymer recommended that dividends be paid for II quarter 2026 in the amount of ₽4.86 per ordinary share. The last day of the purchase of securities to receive dividends is Octobe...
Net profit of MCC Zaymer under IFRS for 6 months of 2026 amounted to RUB 0.921 billion, which is a 2‑fold decrease compared to RUB 1.86 billion in the previous year. Net interest income decreased by 6...
Biopharmaceutical company Promomed has established LLC Promomed‑Pharma to operate in the Uzbek market. Creation of a local company will make it possible to establish direct contacts with the medical a...
Net profit of B2B‑RTS under IFRS for 6 months of 2026 amounted to ₽2 billion, an increase of 9.3% compared to ₽1.83 billion in the previous year. Revenue grew by 14.8% to ₽4.43 billion, compared to ₽3...
Statistics
USERS
PORTFOLIOS
COMPANIES
Mobile app
The mobile application of the service for investors BlackTerminal provides quick access to stock quotes, financial indicators and issuers' multiples.
The analytical coverage of the service includes more than 2200 companies trading on Russian and foreign platforms.
The service provides intermediary services for the selection of undervalued assets and does not carry out brokerage activities.
Any information presented on the site is not an individual investment recommendation and is for informational purposes only.
For possible losses of the investor in the event of transactions, or investing in financial instruments presented on the resource, no one, except the investor himself, bears responsibility.